AmCad BioMed Corporation (4188)
Market Closed
15 Jun, 05:30
TWSE 
NT$
10. 50
-0.05
-0.4739%
NT$
- Market Cap
7.52 P/E Ratio
64% Div Yield
59,208 Volume
0 Eps
NT$ 10.55
Previous Close Want to track 4188 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AmCad BioMed Corporation (4188) Statistics
Valuation metrics
Market Cap -
Enterprise value 673.09M
Trailing P/E (ttm) -11.17
Forward P/E -
PEG ratio 1.7
Price/Sales (ttm) 22.24
Price/Book (mrq) 1.35
Enterprise Value/Revenue 22.4
Enterprise Value/EBITDA -9.57
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 94.14K
Average volume (90 days) 45.92K
Price summary
52-Week low 10.2
52-Week high 17.2
Beta -
50-Day moving average 11.35
200-Day moving average 13.21
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 103:100
Last split Date 27 May 2016
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.02%
Operating margin -2.83%
Operational effectiveness
Return on assets -0.1%
Return on equity -0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.47
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.52
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 23.23%
Book value per share (mrq) 9
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
